JMDC EBIT Margin
The EBIT Margin (Operating Margin) of JMDC (4483.T) as of Jul 25, 2026 is 21.00 %. In the previous year, EBIT Margin (Operating Margin) was 22.26 % — a change of -5.67% (lower).
Get this data via API
Financial Data API
EBIT Margin
21.00 %
YoY
-5.67%
Last updated:
EBIT Margin (Operating Margin) of JMDC is 2026 21.00 % . EBIT Margin (Operating Margin) of JMDC was 2025 22.26 % . It decreases by -5.67% lower compared to the previous year.
For JMDC, the operating (EBIT) margin of 21.0% is down versus 22.1% a few years ago.
Access this data via the Eulerpool API
JMDC Stock analysis
What does JMDC do? The company JMDC Inc is an American company that operates in the fields of information technology and healthcare. The company is based in San Diego, California and was founded in 2004.
The history of JMDC Inc began with the idea of developing innovative software solutions for healthcare. The company started developing software for medical coding and billing to help doctors and hospitals cope with the complexity of medical service billing. Over the years, the company has expanded its business model and products to offer a wider range of services and solutions.
The business model of JMDC Inc is focused on providing IT services and solutions for healthcare. The company focuses on the development and marketing of software products and services that enable efficient and effective management of medical data and information.
The company operates in various segments, each focusing on specific aspects of healthcare. One of the segments is medical coding, which is focused on providing software tools and services to support doctors and hospitals in coding medical services. Another segment of JMDC Inc is medical billing, which aims to simplify and expedite the billing process for medical services.
Another segment of JMDC Inc is electronic medical records, which is focused on providing software solutions and services for storing and managing patient data. This segment also includes the development of solutions for data exchange between various medical facilities.
Another important area of JMDC Inc is software development. The company has built a team of qualified software developers to enable the development of high-quality software solutions for healthcare. The company follows an agile approach to software development and works closely with customers to understand their needs and develop customized solutions.
Products offered by JMDC Inc include software for medical coding, medical billing, electronic medical records, and healthcare data analytics. The software products of JMDC Inc are tailored to the needs of doctors, hospitals, and other medical facilities, providing a user-friendly and effective solution for managing medical data and information.
Overall, JMDC Inc has built a strong presence in healthcare in recent years and has become a key player in the industry. The company is proud to offer innovative solutions that help doctors and hospitals improve their workflows and optimize patient care. JMDC is one of the most popular companies on Eulerpool.
Frequently Asked Questions about JMDC stock
EBIT Margin (Operating Margin) of JMDC is 21.00 % in 2026.
Access this data via the Eulerpool API
Margins — JMDC
All Key Metrics — JMDC
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth